Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatocarcinogenesis (Z#2)/mutagenesis during initiation stage

W S Nichols1, S A Geller, V J Edmond

  • 1Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. nicholsws@csmc.edu

Mutation Research
|June 17, 1998
PubMed
Summary

This study introduces a transgenic mouse model for hepatocellular carcinoma (HCC) research. The model shows early carcinogenesis stages and useful mutation frequencies for in vivo mutagenesis studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MRC2020: improvements to Ximdisp and the MRC image-processing programs.

IUCrJ·2023
Same author

Primary hepatic carcinoid tumor presenting as Cushing's syndrome.

Journal of endocrinological investigation·2007
Same author

Love in the time of Helicobacter.

Experimental biology and medicine (Maywood, N.J.)·2002
Same author

Candida lusitaniae as an unusual cause of recurrent vaginitis and its successful treatment with intravaginal boric acid.

Infectious diseases in obstetrics and gynecology·2002
Same author

Galactomannanases Man2 and Man5 from Thermotoga species: growth physiology on galactomannans, gene sequence analysis, and biochemical properties of recombinant enzymes.

Biotechnology and bioengineering·2001
Same author

Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2001

Area of Science:

  • Hepatocellular Carcinoma Research
  • Transgenic Mouse Models
  • Carcinogenesis Studies

Background:

  • Hepatocellular carcinoma (HCC) is a significant global health concern.
  • Developing accurate animal models for HCC is crucial for understanding disease mechanisms.
  • Previous work established a Z#2 transgenic mouse model for endogenous HCC development.

Purpose of the Study:

  • To evaluate a Z#2 mouse model, also transgenic for the lacI gene, for endogenous carcinogenesis studies.
  • To determine the utility of this double transgenic model for in vivo mutagenesis research.
  • To assess lacI mutant frequency during the initiation phase of carcinogenesis.

Main Methods:

  • Crossing Z#2 mice with Big Blue mice (transgenic for lambda/lacI shuttle vector).

Related Experiment Videos

  • Utilizing five-month-old double transgenic mice (Z#2+/lacI+).
  • Measuring hepatic lacI mutant frequency as a marker for mutagenesis.

    • Main Results:

    • The double transgenic mice exhibited the expected post-inflammatory stage of Z#2 carcinogenesis.
    • Hepatic lacI mutant frequencies were measurable (10^-5 to 10^-4), suitable for mutagenesis studies.
    • A slight increase (< 2x) in hepatic lacI mutation frequencies was observed in Z#2 transgenic mice compared to controls.

    Conclusions:

    • The Z#2+/lacI+ mouse model is suitable for studying endogenous carcinogenesis and in vivo mutagenesis.
    • Further research is needed to reconcile the observed limited lacI mutagenesis with the high incidence of hepatocarcinogenesis.
    • This model provides a valuable tool for investigating the interplay between mutagenesis and cancer initiation.